BRD4 and cancer: In addition to cancer treatment, Brd4 inhibitors have been studied in animal models for the treatment of inflammatory diseases, such as sepsis, multiple sclerosis and liver fibrosis that have been reported to be necroptosis-related diseases [98, 142, 165, 166].